Hirslanden Klinik Im Park – Zentrum für Sportmedizin
- +41 44 209 21 11
- Seestrasse 220, 8027 Zürich, Switzerland
Michael Keogh Consultant Neurologist Newcastle offers expert care in movement disorders and sleep neurology. He provides a unique combination of clinical expertise and advanced research. His work blends patient-focused treatment with cutting-edge genetic studies.
Dr Michael Keogh runs a general neurology clinic every Thursday. He also leads specialist sleep and movement disorder genetics clinics on Wednesdays. These clinics allow him to provide tailored care for patients with complex neurological needs. In each consultation, he focuses on clear communication and individual treatment plans.
His approach connects patients with the latest advances in neurology. This ensures that care is not only effective but also informed by the newest research. Patients benefit from his broad experience and deep knowledge of genetic conditions.
Michael Keogh Consultant Neurologist Newcastle earned his Bachelor of Medical Sciences degree (BMedSci) from Nottingham University. He then gained his medical degree (BMBS) and a Master of Clinical Neurology (MSc) at the same institution. His dedication to advancing medical science led him to complete a post-graduate degree in clinical research (MClinRes) from Newcastle University.
Later, he pursued a PhD at the University of Cambridge in the genetics of neurodegenerative disorders. His work there earned him the Milo Keynes Prize in the Department of Clinical Medicine. Recently, he expanded his expertise with a research fellowship in gene therapy in the USA.
These academic achievements give him a strong foundation for both clinical and research excellence. His education and awards reflect his commitment to improving outcomes for patients with neurological conditions.
Since 2023, Dr Michael Keogh has served as an Honorary Consultant Neurologist and Northern Health Innovation Partners (NHIP) Senior Clinical Fellow. Alongside his clinic work, he is building a research group. This team investigates the genetics of neurodegenerative disorders with a focus on real-world benefits.
Through his combined roles, he connects research directly with patient care. This approach ensures that discoveries move quickly from the lab to the clinic. His long-term vision is to expand treatment options and improve quality of life for people with neurological disease.
